Year: 2004
Type: review
Abstract: Antibodies specific for the β 1 -adrenergic receptor are found in patients with chronic heart failure of various etiologies.From work presented in this issue of the JCI (see the related article beginning on page 1419), we can now infer that these antibodies actually contribute to the pathogenesis of chronic heart failure.This commentary discusses mechanisms by which these antibodies may engender cardiomyopathy.Nonstandard abbreviations used: β-adrenergic receptor (β-AR); β1-adrenergic receptor (β1-AR); chronic systolic heart failure (CHF); cyclic AMP-dependent protein kinase (PKA); G protein-coupled receptor kinase-2 (GRK2); GRK2 carboxyl-terminal polypeptide (GRK2ct); inhibitory heterotrimeric G protein (Gi); stimulatory heterotrimeric GTP-binding protein (Gs). Conflict of interest: R.J. Lefkowitz is cofounder of Norak
DOI: 10.1172/jci21748
Authors: Neil J. Freedman, Robert J. Lefkowitz
Institutions: Duke Medical Center, Howard Hughes Medical Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2044881194
